• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过贝叶斯网络将 EQ-5D-5L 映射到西班牙国家健康调查的功能障碍量表上。

Mapping the EQ-5D-5L from the Spanish national health survey functional disability scale through Bayesian networks.

机构信息

Department of Statistics, School of Law and Social Sciences, University Carlos III of Madrid, 126-28903, Getafe, Madrid, Spain.

Health Service Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.

出版信息

Qual Life Res. 2023 Jun;32(6):1785-1794. doi: 10.1007/s11136-023-03351-y. Epub 2023 Feb 3.

DOI:10.1007/s11136-023-03351-y
PMID:36735174
Abstract

PURPOSE

Preference-based measures are valuable tools for evaluating therapeutic interventions and for cost-effectiveness studies. Mapping procedures are useful when it is not possible to collect these kind of measures. The objective of this study was to evaluate which mapping method is the most appropriate to estimate the EQ-5D-5L index from the Spanish National Health Survey functional disability scale.

METHODS

The sample, formed by 5708 older adults (aged 65 years or older), was drawn from the Spanish National Health Survey ("Encuesta Nacional de Salud en España," ENSE in Spanish 2011-2012). The predictions of EQ-5D-5L index were performed with response mapping using Bayesian network (BN), ordered logit (Ologit), and multinomial logistic (ML). The following direct methods were used: ordinary least squares (OLS) and Tobit regression. The intraclass correlation coefficient (ICC), absolute error (MAE), mean squared error (MSE), and root-mean squared error (RMSE) were calculated to compare all models. The predictions of response models were obtained through the expected value method.

RESULTS

BN model showed the highest ICC (0.756, 95% confidence interval, CI 0.733-0.777) and lowest MAE (0.110, 95% CI 0.104-0.115). OLS was the model with worse accuracy results with lowest ICC (0.621, 95% CI 0.553-0.681) and highest MAE (0.159, 95%CI: 0.145-0.173).

CONCLUSION

Indirect mapping methods (BN, Ologit, and ML) had a better accuracy than the direct methods. The response mapping approach provides a robust method to estimate EQ-5D-5L scores from the functional disability scale.

摘要

目的

偏好量表是评估治疗干预措施和成本效益研究的有用工具。当无法收集此类量表时,映射程序很有用。本研究的目的是评估哪种映射方法最适合从西班牙国家健康调查的功能障碍量表中估算 EQ-5D-5L 指数。

方法

该样本由 5708 名老年人(年龄在 65 岁或以上)组成,来自西班牙国家健康调查(“Encuesta Nacional de Salud en España”,简称 ENSE)(2011-2012 年)。使用贝叶斯网络(BN)、有序逻辑(Ologit)和多项逻辑(ML)进行响应映射,预测 EQ-5D-5L 指数。还使用了以下直接方法:普通最小二乘法(OLS)和 Tobit 回归。计算了组内相关系数(ICC)、绝对误差(MAE)、均方误差(MSE)和均方根误差(RMSE),以比较所有模型。通过期望值法获得响应模型的预测。

结果

BN 模型显示出最高的 ICC(0.756,95%置信区间,0.733-0.777)和最低的 MAE(0.110,95%CI 0.104-0.115)。OLS 是准确性结果最差的模型,其 ICC 最低(0.621,95%CI 0.553-0.681),MAE 最高(0.159,95%CI:0.145-0.173)。

结论

间接映射方法(BN、Ologit 和 ML)比直接方法具有更高的准确性。响应映射方法提供了一种从功能障碍量表中估算 EQ-5D-5L 评分的稳健方法。

相似文献

1
Mapping the EQ-5D-5L from the Spanish national health survey functional disability scale through Bayesian networks.通过贝叶斯网络将 EQ-5D-5L 映射到西班牙国家健康调查的功能障碍量表上。
Qual Life Res. 2023 Jun;32(6):1785-1794. doi: 10.1007/s11136-023-03351-y. Epub 2023 Feb 3.
2
Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.使用多种建模方法将 FACT-B 映射到 EQ-5D-5L:来自中国乳腺癌患者的数据。
Health Qual Life Outcomes. 2019 Oct 15;17(1):153. doi: 10.1186/s12955-019-1224-8.
3
Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.将帕金森特定评分转化为健康状态效用值,以评估成本效用分析。
Patient. 2018 Dec;11(6):665-675. doi: 10.1007/s40271-018-0317-5.
4
Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.开发从肺癌患者 FACT-L 估算 EQ-5D-5L 的算法:一项映射研究。
Qual Life Res. 2024 Mar;33(3):805-816. doi: 10.1007/s11136-023-03567-y. Epub 2023 Dec 26.
5
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.基于 BASDAI 和 BASFI 生成 EQ-5D-5L 健康效用评分:使用英国纵向登记数据的中轴型脊柱关节炎患者的映射研究。
Eur J Health Econ. 2022 Nov;23(8):1357-1369. doi: 10.1007/s10198-022-01429-x. Epub 2022 Feb 3.
6
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.将 ALSFRS-R 和 ALSUI 与运动神经元病患者的 EQ-5D 进行映射。
Value Health. 2018 Nov;21(11):1322-1329. doi: 10.1016/j.jval.2018.05.005. Epub 2018 Jul 26.
7
Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N.中国甲状腺乳头癌的映射研究:从 FACT-H&N 预测 EQ-5D-5L 效用值。
Front Public Health. 2023 Feb 23;11:1076879. doi: 10.3389/fpubh.2023.1076879. eCollection 2023.
8
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.开发映射算法,以根据强直性脊柱炎患者的巴斯强直性脊柱炎疾病活动指数和巴斯强直性脊柱炎功能指数预测EQ-5D健康效用值。
Health Qual Life Outcomes. 2024 Aug 7;22(1):61. doi: 10.1186/s12955-024-02276-5.
9
Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study.利用全国健康和福利研究中特应性皮炎患者的数据,将皮肤病生活质量指数(DLQI)评分映射到 EQ-5D 效用评分。
Qual Life Res. 2020 Sep;29(9):2529-2539. doi: 10.1007/s11136-020-02499-1. Epub 2020 Apr 15.
10
Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis.反应映射方法从 Western Ontario McMaster Universities Osteoarthritis 评估工具(WOMAC)估计髋或膝关节骨关节炎患者的 EQ-5D-5L。
Value Health. 2021 Jun;24(6):874-883. doi: 10.1016/j.jval.2021.01.003. Epub 2021 Mar 31.

引用本文的文献

1
Predicting Health Utilities Using Health Administrative Data: Leveraging Survey-linked Health Administrative Data from Ontario, Canada.利用健康管理数据预测健康效用值:利用来自加拿大安大略省的与调查相关的健康管理数据
Appl Health Econ Health Policy. 2025 Feb 6. doi: 10.1007/s40258-025-00947-y.

本文引用的文献

1
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.癌症特异性 EORTC QLQ-C30 量表与 EQ-5D-5L 效用评分的间接和直接映射。
Appl Health Econ Health Policy. 2022 Jan;20(1):119-131. doi: 10.1007/s40258-021-00682-0. Epub 2021 Sep 23.
2
Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis.反应映射方法从 Western Ontario McMaster Universities Osteoarthritis 评估工具(WOMAC)估计髋或膝关节骨关节炎患者的 EQ-5D-5L。
Value Health. 2021 Jun;24(6):874-883. doi: 10.1016/j.jval.2021.01.003. Epub 2021 Mar 31.
3
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
将 EORTC QLQ-C30 和 FACT-G 量表映射到癌症患者的 EQ-5D-5L 索引上。
Health Qual Life Outcomes. 2020 Nov 3;18(1):354. doi: 10.1186/s12955-020-01611-w.
4
HEALTH-RELATED QUALITY OF LIFE (HRQOL) MEASURES USED IN DANCE: A SYSTEMATIC REVIEW.舞蹈中使用的健康相关生活质量(HRQOL)测量方法:一项系统综述。
Int J Sports Phys Ther. 2020 May;15(3):333-342.
5
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.健康相关生活质量测量指标与通用偏好量表关联(或映射)以生成效用值的研究的更新系统评价。
Appl Health Econ Health Policy. 2019 Jun;17(3):295-313. doi: 10.1007/s40258-019-00467-6.
6
Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.使用混合区间回归方法处理数据质量问题,以估算西班牙 EQ-5D-5L 值集。
Value Health. 2018 May;21(5):596-604. doi: 10.1016/j.jval.2017.10.023. Epub 2017 Dec 2.
7
Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement.回顾和评价将生活质量或临床指标映射到 EQ-5D 的研究:一个在线数据库和 MAPS 声明的应用。
Health Qual Life Outcomes. 2018 Feb 12;16(1):31. doi: 10.1186/s12955-018-0857-3.
8
On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?关于成本效益阈值的估计:为何、是什么、如何?
Value Health. 2016 Jul-Aug;19(5):558-66. doi: 10.1016/j.jval.2016.02.020. Epub 2016 Apr 23.
9
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.映射到基于偏好的结局指标的研究的首选报告项目:MAPS声明。
Pharmacoeconomics. 2015 Oct;33(10):985-91. doi: 10.1007/s40273-015-0319-2.
10
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.适用于基于通用偏好的结局指标的映射研究的MAPS报告声明:解释与阐述
Pharmacoeconomics. 2015 Oct;33(10):993-1011. doi: 10.1007/s40273-015-0312-9.